NIAID RFI – Deployable Clinical Research Support
The National Institute of Allergy and infectious Diseases (NIAID) Division of Clinical Research (DCR) is conducting market research on operational, ...
Tag: NIAID
Positive Results for Combination Ricin, Anthrax Vaccine
Soligenix, Inc. last week announced positive results for the combination of RiVax and VeloThrax to induce protective immunity to both ...
BioThreat Therapeutics Development to Relieve Bottlenecks
The NIAID Division of Microbiology and Infectious Diseases (DMID) has issued a new Broad Agency Announcement (BAA) to support the ...
NIH Launches 3D Print Exchange for Researchers
The National Institutes of Health has launched the NIH 3D Print Exchange, a public website that enables users to share, ...
Notable Contracts: JCVI Genome Center for Infectious Diseases
Scientists from the J. Craig Venter Institute (JCVI), a not-for-profit genomic research organization, have been awarded a five year grant ...
Screen of Drugs Finds Compounds Active against MERS
Clinicians treating patients suffering from Middle East respiratory syndrome (MERS) currently have no drugs specifically targeted to the MERS coronavirus ...
BAA – Multiplex Diagnostic Platforms for Infectious Diseases
The National Institute of Allergy and Infectious Diseases (NIAID) is interested in supporting the advanced development of promising integrated clinical ...
Harvard Launches Three Centers to Battle Infectious Pathogens
In order to better combat infectious disease, Harvard Medical School (HMS) is creating three Centers of Excellence for Translational Research: ...
Penn Vet Identifies Compounds That Control Hemorrhagic Viruses
People fear diseases such as Ebola, Marburg, Lassa fever, rabies and HIV for good reason; they have high mortality rates ...
Scientists Identify Antibodies against Deadly Emerging MERS
Researchers at Dana-Farber Cancer Institute have identified natural human antibodies against the virus that causes Middle East Respiratory Syndrome (MERS), ...
Rutgers Awarded $26M to Lead Development of New Antibiotics
Rutgers infectious disease expert David Perlin leads a team that will use an NIH grant of up to $26 million ...
NIAID Awards $5.3 Million for Influenza POC Diagnostic System
Seattle Children’s Research Institute recently announced that Tim Rose, PhD, co-director of the Center for Global Infectious Disease Research, in ...
NWRCE Funding for Biodefense Career Development
The Northwest Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research (NWRCE) is now accepting proposals for biodefense ...
NIAID Seeks Non-Human Primate Lab Testing Services
The National Institute of Allergy and Infectious Disease (NIAID) has issued a solicitation for non-human primate laboratory testing services. The ...
NIAID Funds $9.4M for Next-Gen Anthrax Vaccine
Biopharmaceutical company Soligenix, through an agreement with Harvard University, will be working towards a next-generation single-dose anthrax vaccine under a $9.4 ...
